skip to Main Content
Press Releases

The 2023 AIM-HI Women’s Venture Competition is Open for Applications!

Have you heard? The application for the 2023 AIM-HI Women’s Venture Competition is now open to women-led, early-stage oncology companies worldwide! Launched by the AIM-HI Accelerator Fund (AIM-HI) in 2020, this one-of-its-kind annual competition empowers women scientist-entrepreneurs in oncology by providing: Unique opportunities to compete for up to $1 million in investment from AIM-HI and…


AIM-HI Accelerator Fund Nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award

The AIM-HI Accelerator Fund is honored to be nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award. The newest Prix Galien Award category, “Incubators, Accelerators and Equity,” acknowledges the role played by organizations in guiding the next wave of innovators, by offering a range of mentoring skills including clinical trial design expertise,…

Leading Game-changing Discoveries | Sujuan Ba, Ph.D.

We’re excited that Dr. Sujuan Ba, AIM-HI CEO & Co-Founder, is featured as one of the “20 Most Inspiring Women Leaders 2022” by THE WOMEN LEADERS Magazine. Read about her illustrious career leading three successful non-profits in the field of cancer research, all the while paving the way for Women in Life Sciences. Her vision has…

AIM-HI CEO & Co-Founder Featured as ‘Scientist Trailblazing the Transformation’

Recently, Sujuan Ba, Ph.D., CEO & Co-Founder of the AIM-HI Accelerator Fund, was featured in the series Profiles in Success as a Scientist Trailblazing the Transformation. In the interview, Dr. Ba highlights her path from determined teen to research and eventually nonprofit leadership. She also shares her advice for being persistent and confident in your passions. “That is…

Support Our Mission

Together, we can make the next generation of cancer treatments a reality.

Back To Top